Argitalpenak (51) SARA ALONSO CASTRO argitalpenak

2023

  1. Acroosteolysis and facial dysmorphia: a new case of Hajdu-Cheney Syndrome

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 527-529

  2. Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index

    Reumatologia Clinica, Vol. 19, Núm. 8, pp. 430-435

  3. Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?

    Journal of Clinical Medicine, Vol. 12, Núm. 5

  4. Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  5. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  6. Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile

    Frontiers in Immunology, Vol. 14

  7. Managing psoriatic arthritis in different clinical scenarios

    Expert Review of Clinical Immunology, Vol. 19, Núm. 12, pp. 1469-1484

2022

  1. Disease impact in axial spondyloarthritis: Divergent roles between family history of disease and HLA-B27?

    Reumatologia Clinica

  2. Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  3. The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis

    The Journal of rheumatology, Vol. 49, Núm. 1, pp. 8-15

2021

  1. ASAS health index as an addition to routine clinical practice

    Journal of Rheumatology

  2. Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

    Frontiers in Medicine, Vol. 8

  3. Inflammation-fatigue in spondyloarthritis: A clear link in axial spondyloarthritis but less so in psoriatic arthritis

    Rheumatology (United Kingdom)

  4. Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

    Frontiers in Medicine, Vol. 8

  5. Sexual disinterest among spondyloarthritis patients. Comparison between psoriatic arthritis and axial spondyloarthritis using a sexuality-specific question from the ASAS Health Index

    Clinical and Experimental Rheumatology

2020

  1. Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study

    Drugs and Aging, Vol. 37, Núm. 2, pp. 99-104

  2. Biological Dose Tapering in Daily Clinical Practice: A 10 Year Follow-up Study

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 319-323

  3. Disease activity in psoriatic arthritis index and psoriatic arthritis impact of disease questionnaire: Correlation and sensitivity to change in a real clinical setting

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 973-977

  4. Family history of disease in spondyloarthritis: a key issue for disease prognosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2657-2658

  5. Performance of the ASAS health index for the evaluation of spondyloarthritis in daily practice

    Journal of Rheumatology, Vol. 47, Núm. 10, pp. 1483-1489